Zap in a cap: How one neurotech startup is using a hat to treat depression FDA approved Motif Neurotech’s application to test its brain implant for treatment-resistant depression in a feasibility trial

https://www.statnews.com/2026/04/27/motif-neurotech-gets-fda-nod-brain-implant-depression/ By O. Rose BroderickApril 27, 2026 Disability in Health Care Reporting Fellow